Status:
RECRUITING
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
Lead Sponsor:
Methodist Health System
Conditions:
Ductal Carcinoma in Situ
Invasive Lobular Breast Carcinoma
Eligibility:
All Genders
18-85 years
Brief Summary
To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).
Detailed Description
Male breast cancer (MBC) is a rare disease without sufficient clinical data supporting the management and treatment. The treatment of MBC arises from data extrapolated from female breast cancer (FBC)....
Eligibility Criteria
Inclusion
- • ≥ 18 years of age Patients diagnosed with ductal carcinoma in situ or invasive lobular carcinoma of the breast
Exclusion
- 18 years of age
- Prisoners
- Pregnant or breastfeeding
Key Trial Info
Start Date :
May 4 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 4 2024
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT06133647
Start Date
May 4 2023
End Date
May 4 2024
Last Update
January 16 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Institute at Methodist Health System
Dallas, Texas, United States, 75203
2
Clinical Research Institute at Methodist Health System
Dallas, Texas, United States, 75203